Natera, Inc. (NTRA) stock
NTRANasdaqServices-Medical LaboratoriesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 10/30140% above fair value
$289.50+2.03 (+0.71%)
Close on Nov 18, 2026Market cap $41.73BP/E –Yield –
Natera net income
Net income is the profit left for shareholders after every expense, interest and tax.
Natera's net income for the twelve months ending Jun 30, 2026 was -$192.35M. For fiscal 2025 it was -$208.16M. The highest annual figure on record is -$5.15M in fiscal 2014.
Annual net income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$208.16M | – |
| FY2024 | Dec 31, 2024 | -$190.43M | – |
| FY2023 | Dec 31, 2023 | -$434.80M | – |
| FY2022 | Dec 31, 2022 | -$547.80M | – |
| FY2021 | Dec 31, 2021 | -$471.72M | – |
| FY2020 | Dec 31, 2020 | -$229.74M | – |
| FY2019 | Dec 31, 2019 | -$124.83M | – |
| FY2018 | Dec 31, 2018 | -$128.15M | – |
| FY2017 | Dec 31, 2017 | -$137.63M | – |
| FY2016 | Dec 31, 2016 | -$100.33M | – |
| FY2015 | Dec 31, 2015 | -$70.28M | – |
| FY2014 | Dec 31, 2014 | -$5.15M | – |
| FY2013 | Dec 31, 2013 | -$37.11M | – |
Quarterly net income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$66.97M | – |
| Q1 FY2026 | Mar 31, 2026 | -$85.09M | – |
| Q4 FY2025 | Dec 31, 2025 | $47.26M | – |
| Q3 FY2025 | Sep 30, 2025 | -$87.54M | – |
| Q2 FY2025 | Jun 30, 2025 | -$100.94M | – |
| Q1 FY2025 | Mar 31, 2025 | -$66.94M | – |
| Q4 FY2024 | Dec 31, 2024 | -$53.77M | – |
| Q3 FY2024 | Sep 30, 2024 | -$31.59M | – |
| Q2 FY2024 | Jun 30, 2024 | -$37.46M | – |
| Q1 FY2024 | Mar 31, 2024 | -$67.60M | – |
| Q4 FY2023 | Dec 31, 2023 | -$78.03M | – |
| Q3 FY2023 | Sep 30, 2023 | -$109.03M | – |
| Q2 FY2023 | Jun 30, 2023 | -$110.80M | – |
| Q1 FY2023 | Mar 31, 2023 | -$136.94M | – |
| Q4 FY2022 | Dec 31, 2022 | -$142.57M | – |
| Q3 FY2022 | Sep 30, 2022 | -$121.48M | – |
| Q2 FY2022 | Jun 30, 2022 | -$145.15M | – |
| Q1 FY2022 | Mar 31, 2022 | -$138.60M | – |
| Q4 FY2021 | Dec 31, 2021 | -$140.56M | – |
| Q3 FY2021 | Sep 30, 2021 | -$151.27M | – |
| Q2 FY2021 | Jun 30, 2021 | -$116.03M | – |
| Q1 FY2021 | Mar 31, 2021 | -$63.85M | – |
| Q4 FY2020 | Dec 31, 2020 | -$76.41M | – |
| Q3 FY2020 | Sep 30, 2020 | -$58.32M | – |
| Q2 FY2020 | Jun 30, 2020 | -$59.64M | – |
| Q1 FY2020 | Mar 31, 2020 | -$35.37M | – |
| Q4 FY2019 | Dec 31, 2019 | -$35.18M | – |
| Q3 FY2019 | Sep 30, 2019 | -$23.14M | – |
| Q2 FY2019 | Jun 30, 2019 | -$32.42M | – |
| Q1 FY2019 | Mar 31, 2019 | -$34.09M | – |
| Q4 FY2018 | Dec 31, 2018 | -$31.84M | – |
| Q3 FY2018 | Sep 30, 2018 | -$29.62M | – |
| Q2 FY2018 | Jun 30, 2018 | -$33.82M | – |
| Q1 FY2018 | Mar 31, 2018 | -$32.87M | – |
| Q4 FY2017 | Dec 31, 2017 | -$47.22M | – |
| Q3 FY2017 | Sep 30, 2017 | -$27.87M | – |
| Q2 FY2017 | Jun 30, 2017 | -$29.07M | – |
| Q1 FY2017 | Mar 31, 2017 | -$33.48M | – |
| Q4 FY2016 | Dec 31, 2016 | -$37.91M | – |
| Q3 FY2016 | Sep 30, 2016 | -$26.02M | – |
See a number that looks wrong?